Results 311 to 320 of about 413,694 (387)

Poster Sessions

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Hepatitis B vaccines

Clinics in Liver Disease, 2004
Immunization is the most effective way to prevent transmission of HBV and, hence, the development of acute or chronic hepatitis B. The national strategy to eliminate transmission of the virus in the United States includes vaccination of all newborn infants, children, adolescents, and high-risk adults.
Emmet B. Keeffe   +3 more
openaire   +6 more sources

Hepatitis B Vaccines [PDF]

open access: possible, 1999
Hepatitis B virus (HBV) chronically infects 200–300 million people worldwide. The resulting acute and chronic disease that results from contact with these individuals or their blood is a leading cause of liver disease, including hepatocellular carcinoma, and mortality. In fact, HBV is second only to smoking as a cause of human cancers (1).
Steven Specter
openaire   +2 more sources

Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature

Science Translational Medicine, 2020
Hepatitis B vaccines formulated with different adjuvants induce a consistent core inflammatory signature linked to vaccine immunogenicity. Patterns of adjuvanticity Understanding how adjuvants improve vaccine-induced immune responses is important for the
Laurane de Mot   +13 more
semanticscholar   +1 more source

Hepatitis B Vaccines [PDF]

open access: possibleNature, 1976
The high rate of infection with hepatitis B virus in certain defined populations in industralized countries and among the general population in many non-industrialized countries stresses the need for hepatitis B vaccines. Hepatitis B, one of at least six different forms of viral hepatitis, may progress to chronic liver disease, including chronic ...
openaire   +3 more sources

Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies.

The Pediatric Infectious Disease Journal, 1993
Yeast-derived recombinant hepatitis B vaccines have replaced plasma-derived vaccines in the United States and have now been given to millions of infants and children throughout the world.
D. Greenberg
semanticscholar   +1 more source

Neonate exposure to thimerosal mercury from hepatitis B vaccines.

American Journal of Perinatology, 2009
Infant exposure to ethylmercury (EtHg) has not only increased but is starting earlier as a result of the current immunization schedule that uses thimerosal-containing vaccines (TCVs).
J. Dórea, R. C. Marques, K. Brandão
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy